At Angiotech, we are redefining success by striving to create novel medical solutions that elevate the standard of care and improve people's lives.
Angiotech is Redefining Success
- Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP). Read More...
If you are a Healthcare Professional and would like to learn more about Angiotech's products, please visit AngioEduPRO.com; Angiotech's Educational Resource for Healthcare Professionals.
Press Releases
- August 22th - Angiotech Announces Extension of the Expiration Date of its Tender Offer Read More...
- August 12th - Angiotech Receives CE Mark Approval of HemoStream™ Chronic Dialysis Catheter Read More...
- July 28th - Angiotech Announces Results for the Second Quarter Ended June 30, 2008 Read More...
- All Press Releases
Highlights
- Angiotech hosted a conference call discussing Second Quarter Financial Results on July 28th Read More...
- Angiotech participated in the Bank of America Health Care Conference in Las Vegas on May 14th Read More...
